MyFinsight
Home
Blog
About
Contact
Download
Download image
Net income
$138,800K
(54.57%↑ Y/Y)
Depreciation
$44,600K
(14.07%↑ Y/Y)
Stock-based compensation
$6,600K
(407.69%↑ Y/Y)
Other non-cash items,
net
-$1,000K
(-134.48%↓ Y/Y)
Non-cash restructuring
charges
$900K
(12.50%↑ Y/Y)
Amortization
$600K
(-33.33%↓ Y/Y)
Asset impairments
$300K
(0.00%↑ Y/Y)
Net cash provided by
operating activities
$89,900K
(-30.53%↓ Y/Y)
Canceled cashflow
$102,900K
Net decrease in cash
and cash...
-$269,900K
(-235.70%↓ Y/Y)
Canceled cashflow
$89,900K
Proceeds from
stock-based compensation...
$5,500K
(120.00%↑ Y/Y)
Employee stock purchase
plan contributions
$2,000K
(5.26%↑ Y/Y)
Changes in assets and
liabilities
$80,300K
(487.92%↑ Y/Y)
something is missing
-$22,600K
Net cash used in
financing activities
-$308,700K
(-110.00%↓ Y/Y)
Canceled cashflow
$7,500K
Net cash used in
investing activities
-$42,700K
(40.11%↑ Y/Y)
Effect of exchange
rates on cash
-$8,400K
(-198.82%↓ Y/Y)
Shares purchased under
share repurchase...
$297,600K
(122.92%↑ Y/Y)
Dividend payments
$15,800K
(3.95%↑ Y/Y)
Shares repurchased for
employee tax...
$2,500K
(0.00%↑ Y/Y)
Principal repayments on
finance leases
$300K
(50.00%↑ Y/Y)
Capital expenditures
$42,700K
(-40.11%↓ Y/Y)
Back
Back
Cash Flow
WEST PHARMACEUTICAL SERVICES INC (WST)
WEST PHARMACEUTICAL SERVICES INC (WST)
source: myfinsight.com